Open access
Open access
Powered by Google Translator Translator

Pharmacology/Pharmaceutical Industry

[Abstract Only] Large Observational Study Suggests No Benefit from Adult Booster Vaccinations Against Tetanus or Diphtheria

26 Feb, 2020 | 06:59h | UTC

Incidence of Tetanus and Diphtheria in Relation to Adult Vaccination Schedules – Clinical Infectious Diseases (link to abstract – $ for full-text)

Commentaries: Adults don’t need tetanus, diphtheria boosters if fully vaccinated as children – Oregon Health & Science University (free) AND Most adults don’t need booster vaccinations for tetanus and diphtheria, new study concludes – STAT (free)

 


Study: Evaluation of a Common Prescribing Cascade of Calcium Channel Blockers and Diuretics in Older Adults with Hypertension

25 Feb, 2020 | 06:42h | UTC

Evaluation of a Common Prescribing Cascade of Calcium Channel Blockers and Diuretics in Older Adults With Hypertension – JAMA Internal Medicine (free for a limited period)

Commentary: Antihypertensive Prescribing Cascades as High-Priority Targets for Deprescribing – JAMA Internal Medicine (free for a limited period)

 

Related Commentary on Twitter

 


Meta-Analysis: Evaluation of the Association Between Gastric Acid Suppression and Risk of Intestinal Colonization with Multidrug-Resistant Microorganisms

25 Feb, 2020 | 06:39h | UTC

Evaluation of the Association Between Gastric Acid Suppression and Risk of Intestinal Colonization With Multidrug-Resistant Microorganisms: A Systematic Review and Meta-analysis – JAMA Internal Medicine (free)

Author Interview: Evaluation of Association Between Gastric Acid Suppression and Risk of Intestinal Colonization With MDROs – JAMA (free)

Commentary: Deprescribing Proton Pump Inhibitors: Overcoming Resistance – JAMA Internal Medicine (free for a limited period)

Related: Deprescribing proton pump inhibitors: Evidence-based clinical practice guideline – Canadian Family Physician (free) AND Deprescribing Proton Pump Inhibitors – Therapeutics Initiative (free)

 

Related Commentary on Twitter

 


JAMA Patient Page: Aspirin for Prevention of Cardiovascular Disease

25 Feb, 2020 | 06:07h | UTC

Aspirin for Prevention of Cardiovascular Disease – JAMA (free)

Related: Aspirin for primary prevention of cardiovascular disease: a meta-analysis with a particular focus on subgroups – BMC Medicine (free) AND Acetylsalicylic acid for primary prevention of cardiovascular events – Canadian Family Physician (free) AND Evidence evolving on aspirin as prevention – ACP Internist (free) AND Benefits and Harms of Aspirin for Primary Prevention of Cardiovascular Disease – Annals of Internal Medicine (link to abstract and commentaries) AND Aspirin for Primary Prevention: Is This the End of the Road? (selection of resources on the subject)

 


[Abstract Only] Meta-Analysis: Lower vs. Standard INR Targets in Atrial Fibrillation

25 Feb, 2020 | 06:04h | UTC

Lower versus Standard INR Targets in Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials – Thrombosis and Haemostasis (link to abstract – $ for full-text)

Source: EvidenceAlerts

 


Cohort Study: Maternal and Fetal Outcomes Following Exposure to Duloxetine in Pregnancy

25 Feb, 2020 | 05:59h | UTC

Maternal and fetal outcomes following exposure to duloxetine in pregnancy: cohort study – The BMJ (free)

 


Meta-Analysis: Comparison of Cardiovascular Events Among Users of Different Classes of Antihypertension Medications

23 Feb, 2020 | 22:10h | UTC

Comparison of Cardiovascular Events Among Users of Different Classes of Antihypertension Medications: A Systematic Review and Network Meta-analysis – JAMA Network Open (free)

 


Cohort Study: Aromatase Inhibitors and the Risk of Cardiovascular Outcomes in Women with Breast Cancer

21 Feb, 2020 | 10:35h | UTC

Aromatase Inhibitors and the Risk of Cardiovascular Outcomes in Women With Breast Cancer: A Population-Based Cohort Study – Circulation (free for a limited period)

 


Meta-Analysis: Individual Differences in Response to Antidepressants

21 Feb, 2020 | 07:33h | UTC

Individual Differences in Response to Antidepressants: A Meta-analysis of Placebo-Controlled Randomized Clinical Trials – JAMA Psychiatry (free for a limited period)

Editorial: Is This Where We Stand After Decades of Research to Develop More Personalized Treatments for Depression? (free for a limited period)

Commentary: How Variable are Patient Responses to Antidepressants? – MedPage Today (free registration required)

 


Randomized Trial: No Evidence That Daily Emollient During the First Year of Life Prevents Eczema

21 Feb, 2020 | 07:28h | UTC

Daily emollient during infancy for prevention of eczema: the BEEP randomised controlled trial – The Lancet (free)

Related Study: Skin emollient and early complementary feeding to prevent infant atopic dermatitis (PreventADALL): a factorial, multicentre, cluster-randomised trial – The Lancet (link to abstract – $ for full-text)

Commentaries: Emollients for prevention of atopic dermatitis in infancy – The Lancet (free) AND Daily moisturizer does not prevent eczema according to new research – News Medical (free)

 

Related Commentary on Twitter

 


Study: A Deep Learning Approach to Antibiotic Discovery

21 Feb, 2020 | 07:23h | UTC

A Deep Learning Approach to Antibiotic Discovery – Cell (free for a limited period)

Commentaries: Powerful antibiotics discovered using AI – Nature (free) AND Aided by machine learning, scientists find a novel antibiotic able to kill superbugs in mice – STAT (free)

 


Cohort Study: Macrolide Antibiotics in Early Pregnancy Linked to Increased Risk of Birth Defects

20 Feb, 2020 | 10:51h | UTC

Associations between macrolide antibiotics prescribing during pregnancy and adverse child outcomes in the UK: population based cohort study – The BMJ (free)

Commentaries: Warning over prescribing antibiotics during pregnancy – OnMedica (free) AND Some antibiotics prescribed during pregnancy linked with birth defects – BMJ (free) AND Expert reaction to study looking at macrolide antibiotics in pregnancy and birth defects – Science Media Centre (free) AND Macrolide Antibiotics Early in Pregnancy Tied to Birth Defects – The New York Times (10 articles per month are free)

 


Meta-Analysis: Insufficient Evidence that Herbal Medicines are Effective for Weight Loss

19 Feb, 2020 | 10:16h | UTC

Effectiveness of herbal medicines for weight loss: A systematic review and meta‐analysis of randomized controlled trials – Diabetes, Obesity and Metabolism (free)

Commentary: Insufficient evidence backing herbal medicines for weight loss – University of Sidney (free)

 


Opinion: “Without Oversight, Electronic Prescribing Can Harm Patients”

19 Feb, 2020 | 08:25h | UTC

Without oversight, electronic prescribing can harm patients – STAT (free)

 


Large Observational Study Suggests Hydrochlorothiazide may be as Effective as Chlortalidone with Less Adverse Effects

18 Feb, 2020 | 08:17h | UTC

Comparison of Cardiovascular and Safety Outcomes of Chlorthalidone vs Hydrochlorothiazide to Treat Hypertension – JAMA Internal Medicine (free for a limited period)

Commentary: Hypertension Treatments with Chlorthalidone vs HCTZ: Cardiac and Safety Outcomes – MedicalResearch.com (free)

 


[Abstract Only] Randomized Trial: Adverse Effects of Low-Dose Methotrexate

18 Feb, 2020 | 08:08h | UTC

Adverse Effects of Low-Dose Methotrexate: A Randomized Trial – Annals of Internal Medicine (link to abstract – $ for full-text)

Commentaries: Study investigates rates of adverse events for common rheumatoid arthritis drug – Brigham and Women’s Hospital (free) AND Low-dose methotrexate use ‘has inherent risks’ – Medicine Matters (free)

 


Opinion Article – Use of Methylphenidate Analogues as Cognitive Enhancers: The Prelude to Cosmetic Neurology and an Ethical Issue

18 Feb, 2020 | 08:03h | UTC

Use of Methylphenidate Analogues as Cognitive Enhancers: The Prelude to Cosmetic Neurology and an Ethical Issue – Frontiers in Psychiatry (free)

Related: Perspective: Use of ‘Smart Drugs’ on the Rise (several texts on the subject)

 


FDA Requests the Withdrawal of the Weight-loss Drug Lorcaserin from the Market – Potential Risk of Cancer Outweighs the Benefits

16 Feb, 2020 | 21:33h | UTC

FDA requests the withdrawal of the weight-loss drug Belviq, Belviq XR (lorcaserin) from the market Potential risk of cancer outweighs the benefits – U.S. Food & Drug Administration (free)

Source: Lorcaserin (Belviq ) Withdrawn From US Market Due to Cancer Risk – Medscape (free registration required)

Related: FDA Safety Communication: Possible Increased Risk of Cancer with Weight-loss Medicine Lorcaserin (free)

 


[Abstract Only] Study: An Electroencephalographic Signature Predicts Antidepressant Response in Major Depression

16 Feb, 2020 | 21:27h | UTC

An electroencephalographic signature predicts antidepressant response in major depression – Nature Biotechnology (link to abstract – $ for full-text)

Commentaries: Neural signature identifies people likely to respond to antidepressant medication – NIH News Releases (free) AND Brain-wave pattern can identify people likely to respond to antidepressant, study finds – Stanford Medicine (free) AND AI, brain scans may alter how doctors treat depression – UT Southwestern Medical Center (free) AND Brain scans could be used to identify who will benefit from antidepressants – Business Insider (free) AND Resting-State EEG Can Predict Sertraline Treatment Outcomes – MPR (free) AND Will That Antidepressant Work For You? The Answer May Lie In Your Brain Waves – NPR (free)

 


Principles of Vaccine Licensure, Approval, and Recommendations for Use

16 Feb, 2020 | 20:41h | UTC

Principles of Vaccine Licensure, Approval, and Recommendations for Use – Mayo Clinic Proceedings (free)

 


Recommended Childhood and Adolescent Immunization Schedule: United States, 2020

13 Feb, 2020 | 08:09h | UTC

Recommended Childhood and Adolescent Immunization Schedule: United States, 2020 – Pediatrics (free)

Table 1. Recommended Child and Adolescent Immunization Schedule for ages 18 years or younger, United States, 2020 – Centers for Disease Control and Prevention (free)

Table 2. Catch-up immunization schedule for persons aged 4 months–18 years who start late or who are more than 1 month behind, United States, 2020 – Centers for Disease Control and Prevention (free)

Table 3. Recommended Child and Adolescent Immunization Schedule by Medical Indication, United States, 2020 – Centers for Disease Control and Prevention (free)

 


NICE Guideline: Antimicrobial Prescribing for Leg Ulcer Infection

12 Feb, 2020 | 07:35h | UTC

Leg ulcer infection: antimicrobial prescribing – National Institute for Health and Care Excellence (free)

Related: NICE Antimicrobial prescribing guidelines (resource covering many common conditions) AND NICE Summary of antimicrobial prescribing guidance – managing common infections (free PDF)

 

Related Commentary on Twitter

 


[Abstract Only] Another Study Suggesting One Dose of HPV Vaccine may be Effective for Prevention of Cervical Cancer

11 Feb, 2020 | 01:52h | UTC

Comparison of the long‐term impact and clinical outcomes of fewer doses and standard doses of human papillomavirus vaccine in the United States: A database study – Cancer (link to abstract – $ for full-text)

Commentaries: Single HPV vaccine dose may be effective against cervical cancer – Wiley (free) AND Expert reaction to study on single dose of HPV vaccine – Science Media Centre (free)

Related: Another Observational Study Suggests One Dose of HPV Vaccine may be Enough (free studies)

 


Psychopharmacological Treatment in Older People: Avoiding Drug Interactions and Polypharmacy

9 Feb, 2020 | 20:21h | UTC

Psychopharmacological Treatment in Older People: Avoiding Drug Interactions and Polypharmacy – Deutsches Ärzteblatt international (free)

 


Review: Drugs for Some Common Eye Disorders

9 Feb, 2020 | 20:15h | UTC

Drugs for Some Common Eye Disorders – JAMA (free for a limited period)

If the link above does not work, try this one

 

Related Commentary on Twitter

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.